Z-0310-2022 Class II Ongoing

Recalled by DRG International, Inc. — Springfield, NJ

FDA device recall Z-0310-2022 was initiated by DRG International, Inc. on Oct 18, 2021 and is designated Class II. Reason for recall: Firm has identified two lots of product that do not meet product shelf life, resulting in failed Controls. The clinical impact may be a delay in diagnosis and a consumption of patient samples. The recall status is ongoing. Affected quantity: 314 total (270 US).

Recall details

Product Type
Devices
Report Date
Dec 8, 2021
Initiation Date
Oct 18, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
314 total (270 US)

Product description

Total Thyroxine (T4) ELISA; REF EIA-1781

Reason for recall

Firm has identified two lots of product that do not meet product shelf life, resulting in failed Controls. The clinical impact may be a delay in diagnosis and a consumption of patient samples.

Distribution pattern

Domestic: NY; International: TZ, VN, BD, CO, TT, YE, BO, DE, SV, GE, PY, TG, RU/UA, NI, DO, NG, EG & CM

Code information

lot#: RN-60923 expiration date 12/31/2021; RN-60831 expiration date 12/31/2021

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0310-2022
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0310-2022. Report a data issue: hello@regdatalab.com.